Skip to content
Search

Latest Stories

Covid-19 booster vaccine programme to begin next week

The UK government today (September 14) announced the nine groups that are most vulnerable to Covid-19 will be eligible for a third booster dose of vaccine, six months after their second dose.

Health and Social Care secretary Sajid Javid told the Commons that the government has accepted the advice of the Joint Committee on Vaccination and Immunisation (JCVI) on booster jabs, and the NHS is preparing to offer Covid booster vaccine from next week.


Under the booster programme around 30 million people are likely to be offered a third dose.

More than 112,000 lives were saved and 24 million cases were averted because of Covid-19 vaccines, British officials said while recommending a booster shot for all vulnerable people, earlier today.

In its recommendation to the government, the JCVI has given preference to the Pfizer-BioNTech vaccine for the booster programme or alternatively a half-dose of a Moderna shot.

The committee has advised administering booster jab to those living in residential care homes for older adults, adults aged 50 years or over, frontline health and social care workers, adult contacts of immunosuppressed individuals and all those aged 16 to 49 years with serious health condition.

The advice comes ahead of an announcement by the government on its strategy for taming infections during this winter.

Professor Wei Shen Lim, chair of Covid-19 immunisation for the JCVI, said, “the main aim of the booster programme is to prolong that protection and reduce serious disease as we head towards the colder months.

“The JCVI is advising that a booster dose be offered to the more vulnerable, to maximise individual protection ahead of an unpredictable winter. Most of these people will also be eligible for the annual flu vaccine and we strongly advise them to take up this offer as well.”

Commenting on the Covid-19 vaccination booster programme announcement, Ruth Rankine, director of primary care at the NHS Confederation, said: “Our members will welcome confirmation of this final decision following weeks of uncertainty about the plans. Primary care has played a crucial part in the highly successful roll out of the vaccination programme to date and will continue to deliver to protect their patients and the public.”

She, however, noted that delivering booster programme along with the government’s recent decision to vaccinate 12–15-year-olds will require more time and investment.

She said: “we must also acknowledge the amount of time and investment that will be needed to deliver both these programmes alongside the flu vaccination programme, set against what is already an extremely busy time with primary care seeing a huge increase in demand coupled with increasingly complex cases, and managing patients waiting for secondary care treatment.”

More For You

Infant formula: Food, diet and obesity committee welcomes CMA proposals, demands action on processed foods
CMA study shows that parents could save around £300 a year by switching to a lower priced infant formula brand (gettyimages)

Infant formula: CMA calls for stronger labelling and advertising rules

All infant formula brands should be displayed together and separately from other formula milks in stores to enable quick and easy price comparisons – suggests CMA 

The Competition and Marketing Authority (CMA) has recommended the governments of the four UK nations to strengthen advertising and labelling rules of infant formula to help parents make informed decisions and save money.

This follows a CMA study on infant formula and follow-on milks, which found that a combination of factors was leading to poor outcomes for parents.

Keep ReadingShow less
David Thomas Steps In as NPA’s New Wales Representative
Five NPA members are contesting for the remaining position in England (gettyimages)

NPA board update: David Thomas succeeds Raj Aggarwal OBE

Five NPA members are contesting for the remaining position in England

David Thomas, owner of LT Chemists in Newport, will replace Raj Aggarwal OBE as the next National Pharmacy Association (NPA) board member for Wales, following an uncontested election this month.

Following the conclusion of a nomination process last week, Baldev Bange, Aisling O’Brien, Sehar Shahid, and Sanjay Ganvir have been re-elected to the Board, representing areas of England and Scotland, according to a statement from NPA.

Keep ReadingShow less
Public Policy Projects calls for better use of community pharmacy skill mix to improve medicines adherence
Non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed. (gettyimages)

Leverage pharmacy skill mix to improve medicines adherence - report suggests

The report also suggested expanding the community pharmacy contractual framework to enable community pharmacy to deliver medicines reviews

Pharmacy technicians and assistants should be enabled to talk to patients about their medications to improve medicines adherence, a new report has recommended.

The report, How medicines optimisation contributes to population health, published recently by policy institute Public Policy Projects, highlighted that non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed.

Keep ReadingShow less
GHP calls for 10% mandated protected learning time for NHS pharmacists in new campaign
Many pharmacists end up doing ‘unpaid work’ to catch up with the required training (gettyimages)

Increase protected learning time for NHS pharmacists – GHP launches national campaign

Many pharmacists end up doing ‘unpaid work’ to catch up with the required training or completing self-learning in their own time.

The Guild of Healthcare Pharmacists (GHP) has launched a national campaign advocating for pharmacists working in the NHS to have a minimum of 10% of their contracted hours protected for supporting professional activities (SPA).

In a statement published on 7 February 2025, the GHP emphasised that this protected time “should be recognized by employers and embedded in job plans.”

Keep ReadingShow less
Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Kinnock confirms that an announcement on the 2025/26 GP contract would be made before April 2025

The 2025/26 pharmacy contract consultation will include a review of the medicine margin and reimbursement arrangements, health and care minister Stephen Kinnock has confirmed.

Kinnock made this statement in response to a written question from Nick Timothy, Conservative MP for West Suffolk, who asked the secretary of state for health and social care, if he will review the reimbursement system for pharmacies and GP practices dispensing medicines.

Keep ReadingShow less